Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Dimitroulas

Showing results (171-180 of 191) with videos related to

Pageof 20
Sort By:
Rheumatology (Oxford, England)|November 26, 2019
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS)Sophie Mavrogeni, Luna Gargani, Alessia Pepe, et al.
Rheumatology International|March 1, 2023
Apremilast for biologic-naïve, peripheral psoriatic arthritis, including patients with early disease: results from the APROACH observational prospective studyPetros P Sfikakis, Dimitrios Vassilopoulos, Gkikas Katsifis, et al.
Rheumatology International|July 4, 2026
Computational intelligence using nailfold videocapillaroscopy for the prediction of carotid intima-media thickness in rheumatoid arthritis: a cohort-based studyDanial J Armaghani, Elena Angeloudi, Amir H Gandomi, et al.
Rheumatology (Oxford, England)|October 30, 2025
Comparable 12-month renal response outcomes with medium vs. high-dose starting prednisone in a real-world study of lupus nephritisMaria Pappa, Sofia Flouda, Antigone Pieta, et al.
RMD Open|September 19, 2024
Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational studyMaria Pappa, Maria Kosmetatou, Antigone Pieta, et al.
Therapeutic Advances in Musculoskeletal Disease|October 16, 2020
Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patientsKonstantinos Thomas, Argiro Lazarini, Evripidis Kaltsonoudis, et al.
Annals of the Rheumatic Diseases|November 11, 2021
Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseasesCharalampos Papagoras, George E Fragoulis, Nikoleta Zioga, et al.
Clinical Rheumatology|September 21, 2023
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseasesCharalampos Papagoras, Nikoleta Zioga, Vasileios Papadopoulos, et al.
International Journal of Cardiology|May 16, 2016
Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for useSophie I Mavrogeni, George D Kitas, Theodoros Dimitroulas, et al.
Mediterranean Journal of Rheumatology|January 29, 2024
Disease Profile and Achievement of Therapeutic Goals in a Modern, Nationwide Cohort of 923 Patients with Psoriatic ArthritisGeorge E Fragoulis, Charalampos Papagoras, Sousana Gazi, et al.
Pageof 20

Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Rheumatology (Oxford, England)|November 26, 2019
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS)Sophie Mavrogeni, Luna Gargani, Alessia Pepe, et al.
Rheumatology International|March 1, 2023
Apremilast for biologic-naïve, peripheral psoriatic arthritis, including patients with early disease: results from the APROACH observational prospective studyPetros P Sfikakis, Dimitrios Vassilopoulos, Gkikas Katsifis, et al.
Rheumatology International|July 4, 2026
Computational intelligence using nailfold videocapillaroscopy for the prediction of carotid intima-media thickness in rheumatoid arthritis: a cohort-based studyDanial J Armaghani, Elena Angeloudi, Amir H Gandomi, et al.
Rheumatology (Oxford, England)|October 30, 2025
Comparable 12-month renal response outcomes with medium vs. high-dose starting prednisone in a real-world study of lupus nephritisMaria Pappa, Sofia Flouda, Antigone Pieta, et al.
RMD Open|September 19, 2024
Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational studyMaria Pappa, Maria Kosmetatou, Antigone Pieta, et al.
Therapeutic Advances in Musculoskeletal Disease|October 16, 2020
Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patientsKonstantinos Thomas, Argiro Lazarini, Evripidis Kaltsonoudis, et al.
Annals of the Rheumatic Diseases|November 11, 2021
Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseasesCharalampos Papagoras, George E Fragoulis, Nikoleta Zioga, et al.
Clinical Rheumatology|September 21, 2023
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseasesCharalampos Papagoras, Nikoleta Zioga, Vasileios Papadopoulos, et al.
International Journal of Cardiology|May 16, 2016
Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for useSophie I Mavrogeni, George D Kitas, Theodoros Dimitroulas, et al.
Mediterranean Journal of Rheumatology|January 29, 2024
Disease Profile and Achievement of Therapeutic Goals in a Modern, Nationwide Cohort of 923 Patients with Psoriatic ArthritisGeorge E Fragoulis, Charalampos Papagoras, Sousana Gazi, et al.
Pageof 20